You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 19, 2024

Claims for Patent: 5,993,810

✉ Email this page to a colleague

« Back to Dashboard

Summary for Patent: 5,993,810

Title:	Method of softening or ripening the cervix of a female mammal using collagenase
Abstract:	The present invention relates to the use of collagenase and/or one more substances which stimulate the production of naturally occurring collagenase in the cervix to induce labor in a female mammal, and in particular a female human or to terminate pregnancy in such a female mammal. The substances which stimulate the production of naturally occurring collagenase include Interleukin 1 beta, Interleukin 2, Interleukin 6, Interleukin 8 and tumor necrosis factor.
Inventor(s):	Lebovitz; Shamir Israel (Tel Aviv, IL)
Assignee:
Application Number:	08/818,205
Patent Claims:	1. A method of softening or ripening the cervix of a female mammal, comprising administering a cervical-ripening amount of a collagenase to the cervix of said female mammal. 2. The method of claim 1 wherein said female mammal is human. 3. The method of claim 1 wherein the composition further comprises a substance selected from the group consisting of Interleukin 1 beta, Interleukin 6, Interleukin 8 and tumor necrosis factor. 4. A method of inducing labor in a female mammal, comprising administering a cervical-ripening amount of a collagenase to the cervix of said female mammal and thereafter an effective amount of a prostaglandin or oxytocin to said female mammal. 5. The method of claim 4 wherein said female mammal is human. 6. The method of claim 4 wherein the composition further comprises a substance selected from the group consisting of Interleukin 1 beta, Interleukin 6, Interleukin 8 and tumor necrosis factor. 7. A method of terminating pregnancy in a female mammal, comprising administering 1) a cervical-ripening amount of a collagenase to the cervix of said female mammal and thereafter 2) an effective amount of a prostaglandin or oxytocin to said female mammal. 8. The method of claim 7 wherein the composition further comprises a substance selected from the group consisting of Interleukin 1 beta, Interleukin 6, Interleukin 8 and tumor necrosis factor. 9. The method of claim 7 wherein said female mammal is human. 10. A method of ripening the cervix of a female mammal before diagnostic or operative procedures comprising administering a cervical-ripening amount of collagenase to the cervix of said female mammal. 11. The method of claim 10 further comprising administering a substance selected from the group consisting of Interleukin 1 beta, Interleukin 6, Interleukin 8 and tumor necrosis factor and combinations thereof. 12. The method of claim 10 wherein said female mammal is human. 13. The method of claim 1, wherein the amount of collagenase administered is an amount sufficient to provide a concentration in the range of from about 10 to about 200 I.U. per gram cervical tissue. 14. The method of claim 1, wherein the amount of collagenase administered is an amount sufficient to provide a concentration in the range of from about 10 to about 15 I.U. per gram cervical tissue. 15. The method of claim 4, wherein the amount of collagenase administered is an amount sufficient to provide a concentration in the range of from about 10 to about 200 I.U. per gram cervical tissue. 16. The method of claim 4, wherein the amount of collagenase administered is an amount sufficient to provide a concentration in the range of from about 10 to about 15 I.U. per gram cervical tissue. 17. The method of claim 7, wherein the amount of collagenase administered is an amount sufficient to provide a concentration in the range of from about 10 to about 200 I.U. per gram cervical tissue. 18. The method of claim 7, wherein the amount of collagenase administered is an amount sufficient to provide a concentration in the range of from about 10 to about 15 I.U. per gram cervical tissue. 19. The method of claim 10, wherein the amount of collagenase administered is an amount sufficient to provide a concentration in the range of from about 10 to about 200 I.U. per gram cervical tissue. 20. The method of claim 10, wherein the amount of collagenase administered is an amount sufficient to provide a concentration in the range of from about 10 to about 15 I.U. per gram cervical tissue. 21. The method of claim 10 wherein the collagenase is recombinant collagenase. 22. The method of claim 7, wherein said prostaglandin is pgE.sub.2 .alpha. or pgF.sub.2 .alpha. and said prostaglandin is administered extra-amniotically.

Details for Patent 5,993,810

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Smith & Nephew, Inc.	SANTYL	collagenase	Ointment	101995	06/04/1965	⤷ Try a Trial	2016-03-15
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.